Stereotaxis, Inc. (STXS)

NYSEAMERICAN: STXS · IEX Real-Time Price · USD
2.610
+0.100 (3.98%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room.

In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters.

Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components.

It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures.

Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Stereotaxis, Inc.
Stereotaxis logo
Country United States
Founded 1990
IPO Date Aug 12, 2004
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 122
CEO Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.

Contact Details

Address:
710 N Tucker Blvd, Ste 110
St.louis, Missouri 63101
United States
Phone 314-678-6100
Website stereotaxis.com

Stock Details

Ticker Symbol STXS
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001289340
CUSIP Number 85916J409
ISIN Number US85916J4094
Employer ID 94-3120386
SIC Code 3845

Key Executives

Name Position
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. Chief Executive Officer and Chairman
Kimberly R. Peery Chief Financial Officer and Secretary
Keith Galloway Vice President of Operations
Laura Spencer Garth General Counsel and Secretary
Guy Judkowski Equity Portfolio Manager

Latest SEC Filings

Date Type Title
Mar 8, 2024 10-K Annual Report
Mar 4, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2023 10-Q Quarterly Report
Nov 9, 2023 8-K Current Report
Aug 11, 2023 10-Q Quarterly Report
Aug 10, 2023 8-K Current Report
Jun 15, 2023 8-K Current Report
Jun 6, 2023 EFFECT Notice of Effectiveness
Jun 6, 2023 EFFECT Notice of Effectiveness